Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,667 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022.
Ozaki Y, Hara H, Onuma Y, Katagiri Y, Amano T, Kobayashi Y, Muramatsu T, Ishii H, Kozuma K, Tanaka N, Matsuo H, Uemura S, Kadota K, Hikichi Y, Tsujita K, Ako J, Nakagawa Y, Morino Y, Hamanaka I, Shiode N, Shite J, Honye J, Matsubara T, Kawai K, Igarashi Y, Okamura A, Ogawa T, Shibata Y, Tsuji T, Yajima J, Iwabuchi K, Komatsu N, Sugano T, Yamaki M, Yamada S, Hirase H, Miyashita Y, Yoshimachi F, Kobayashi M, Aoki J, Oda H, Katahira Y, Ueda K, Nishino M, Nakao K, Michishita I, Ueno T, Inohara T, Kohsaka S, Ismail TF, Serruys PW, Nakamura M, Yokoi H, Ikari Y; Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Cardiovascular Interventional Therapeutics (CVIT). Ozaki Y, et al. Among authors: tsuji t. Cardiovasc Interv Ther. 2022 Jan;37(1):1-34. doi: 10.1007/s12928-021-00829-9. Epub 2022 Jan 12. Cardiovasc Interv Ther. 2022. PMID: 35018605 Free PMC article. Review.
The Japanese Association of Cardiovascular Intervention and Therapeutics position statement on coronary invasive procedures during the COVID-19 pandemic in Japan.
Ikari Y, Yamada S, Ehara N, Kozuma K, Shinke T, Sugano T, Seike F, Sonoda S, Tazaki J, Tsuji T, Mibiki Y, Muramatsu T, Morita T, Sawano M. Ikari Y, et al. Among authors: tsuji t. Cardiovasc Interv Ther. 2021 Apr;36(2):139-144. doi: 10.1007/s12928-021-00767-6. Epub 2021 Mar 22. Cardiovasc Interv Ther. 2021. PMID: 33748929 Free PMC article. No abstract available.
Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents.
Nishio S, Kosuga K, Igaki K, Okada M, Kyo E, Tsuji T, Takeuchi E, Inuzuka Y, Takeda S, Hata T, Takeuchi Y, Kawada Y, Harita T, Seki J, Akamatsu S, Hasegawa S, Bruining N, Brugaletta S, de Winter S, Muramatsu T, Onuma Y, Serruys PW, Ikeguchi S. Nishio S, et al. Among authors: tsuji t. Circulation. 2012 May 15;125(19):2343-53. doi: 10.1161/CIRCULATIONAHA.110.000901. Epub 2012 Apr 16. Circulation. 2012. PMID: 22508795
Two-year clinical outcome in patients with small coronary artery disease treated with everolimus- versus paclitaxel-eluting stenting.
Nasu K, Oikawa Y, Shirai S, Hozawa H, Kashima Y, Tohara S, Kadotani M, Gotoh R, Ujiie Y, Tanabe M, Abe H, Okamura A, Tsuji T, Suzuki M, Takeda Y, Mibiki Y, Ota H, Usui S, Nakagawa Y, Kawaguchi R, Yamashita J, Serikawa T, Aizawa T, Suzuki T; SACRA and PLUM registries investigators. Nasu K, et al. Among authors: tsuji t. J Cardiol. 2016 Sep;68(3):209-14. doi: 10.1016/j.jjcc.2015.08.024. Epub 2015 Oct 9. J Cardiol. 2016. PMID: 26454428 Free article.
Decade of histological follow-up for a fully biodegradable poly-L-lactic acid coronary stent (Igaki-Tamai stent) in humans: are bioresorbable scaffolds the answer?
Nishio S, Takeda S, Kosuga K, Okada M, Kyo E, Tsuji T, Takeuchi E, Terashima T, Inuzuka Y, Hata T, Takeuchi Y, Harita T, Seki J, Ikeguchi S. Nishio S, et al. Among authors: tsuji t. Circulation. 2014 Jan 28;129(4):534-5. doi: 10.1161/CIRCULATIONAHA.113.003769. Circulation. 2014. PMID: 24470476 No abstract available.
3,667 results